HomeHealthcareBiotechnologyGlobal Platelet Rich Plasma Market

Global Platelet Rich Plasma Market - Forecasts from 2018 to 2023

📥 Download Free Sample💬 Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewTable of ContentsCustomize Report

Report Overview

The global Platelet Rich Plasma market is expected to reach $XX billion by 2023 from $XX billion in 2017 growing at a CAGR of XX%.  Platelets or thrombocytes are the tiny blood cells that form clots or plug at the site of injury to stop bleeding. They are produced in bone marrow along with the white and red blood cells. A normal platelet count is 150,000 to 450,000 platelets per microliter of blood. Blood plasma is the liquid portion of blood in which blood cells are suspended. It acts as transport medium for delivering nutrients to the cells of the various organs of the body and for transporting waste products derived from cellular metabolism to the kidneys, liver, and lungs for excretion. Blood Platelet and Plasma market is expected to show significant growth during the forecast period due to rising number of patients requiring plasma and platelet transfusion throughout the world. Growing use of platelet-rich plasma in various therapeutic areas will also augment the growth of the market. However, high cost of the plasma therapy might restrict the growth of the market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Platelet Rich Plasma market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Platelet Rich Plasma market.

Major industry players profiled as part of the report are MabPlex Inc. , ATUM and Selexis among others.

Segmentation

By Type

Pure Platelet-Rich Plasma (P-PRP) or Leukocyte-Poor Platelet-Rich Plasma

Leukocyte-and Platelet-Rich Plasma (L-PRP)

Pure Platelet-Rich Fibrin (P-PRF)

Leukocyte- and Platelet-Rich Fibrin (L-PRF)


By Source

Autologous

Allogenic

Homologous


By Application

Orthopedic Surgery

Neurosurgery

General Surgery

Others


By End Users

Hospitals and Clinics

Research Institutes

Ambulatory Surgical Centers


By Geography

North America

United States

Canada

Others


South America

Brazil

Argentina

Others


Europe

United Kingdom

Germany

France

Others


Middle East and Africa

Saudi Arabia

UAE

Israel

Others


Asia Pacific

China

India

Australia

South Korea

Others

 

Key questions answered by the report

What will be the global Platelet Rich Plasma market size from 2018 to 2023?

How are the major drivers and restraints affecting the global Platelet Rich Plasma market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth

REPORT DETAILS

Report ID:KSI061612089
Published:May 2019
Pages:114
Format:PDF, Excel, PPT, Dashboard
📥 Download Sample📞 Speak to Analyst📧 Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The Global Platelet Rich Plasma - Forecasts from 2018 to 2023 Market is expected to reach significant growth by 2030.

Key drivers include increasing demand across industries, technological advancements, favorable government policies, and growing awareness among end-users.

This report covers North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with detailed country-level analysis.

This report provides analysis and forecasts from 2025 to 2030.

The report profiles leading companies operating in the market including major industry players and emerging competitors.

Related Reports

Healthcare

Platelets Rich Plasma Market Size, Share, Opportunities, And Trends By Type (Pure Platelet-Rich Plasma, Leukocyte-and Platelet-Rich Plasma, Pure Platelet-Rich Fibrin, Leukocyte- and Platelet-Rich Fibrin), By Source (Autologous, Allogenic, Homologous), By Application (Orthopedic Surgery, Neurosurgery, General Surgery, Others), By End User (Hospitals and Clinics, Research Institutes, Ambulatory Surgical Centers), And By Geography - Forecasts From 2025 to 2030

May 2025
View All Reports